Skip to content
ppharmaranks
Menu

Lisinopril: uses, dosing, side effects & brands

Lisinopril is an angiotensin converting enzyme inhibitor sold in the U.S. under 3 brand and generic names, for diabetic nephropathies, heart failure and hypertension. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Drug class
Angiotensin Converting Enzyme Inhibitor
Treats (across its forms)
Diabetic Nephropathies, Heart Failure and Hypertension
Available as
Tablet · Solution
Sold as
3 products — Lisinopril, Prinivil and Qbrelis
Prescription?
Prescription only
Generic available?
Yes
Half-life
about 12 hours (the effective half-life, in adults with normal kidney function)
What the pharmacy pays
about $0.77 for a 30-count supply — not your price
Boxed warning
Boxed warning

Get treated for Lisinopril conditions online

Licensed online providers — consult & get prescribed if eligible.

Advertising disclosure: We may earn a commission, at no extra cost to you. This never affects our ratings. Details

How Qbrelis is dosed

From the FDA label for Qbrelis (application NDA208401). Other lisinopril products — different forms, different strengths — are dosed differently. Follow the label for the one you were prescribed.

Hypertension: Initial adult dose is 10 mg once daily. Titrate up to 40 mg daily based on blood pressure response. Initiate patients on diuretics at 5 mg once daily ( 2.1 ). Pediatric patients with glomerular filtration rate > 30 mL/min/1.73m 2 : Initial dose in patients 6 years of age and older is 0.07 mg per kg (up to 5 mg total) once daily ( 2.1 ). Heart Failure: Initiate with 5 mg once daily. Increase dose as tolerated to 40 mg daily ( 2.2 ). Acute Myocardial Infarction (MI): Give 5 mg within 24 hours of MI followed by 5 mg after 24 hours, then 10 mg once daily ( 2.3 ). Renal Impairment: For patients with creatinine clearance ≥ 10 mL/min and ≤ 30 mL/min, halve usual initial dose. For patients with creatinine clearance < 10 mL/min or on hemodialysis, the recommended initial dose is 2.5 mg ( 2.4 ). 2.1 Hypertension Adults Initial Therapy in adults: The recommended initial dose is 10 mg taken orally once a day. Adjust dosage as needed according to blood pressure response. The usual dosage range is 20 to 40 mg per day administered in a single daily dose. Doses up to 80 mg per day have been used but do not appear to give greater effect. Use with diuretics in adults If blood pressure is not controlled with QBRELIS alone, a low dose of a diuretic may be added (e.g., hydrochlorothiazide, 12.5 mg). After the addition of a diuretic, it may be possible to reduce the dose of QBRELIS.…

Everything below is the FDA label for Qbrelis (solution). Lisinopril is also sold as tablet, and those are different medicines to take — follow the label for the one you were prescribed.

Qbrelis side effects

Common adverse reactions (events 2% greater than placebo) by use: Hypertension: headache, dizziness and cough ( 6.1 ). Heart Failure: hypotension and chest pain ( 6.1 ). Acute Myocardial Infarction: hypotension ( 6.1 ). To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc., at 1-800-461-7449 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice. Hypertension In clinical trials in patients with hypertension treated with lisinopril, 5.7% of patients on lisinopril discontinued with adverse reactions. The following adverse reactions (events 2% greater on lisinopril than on placebo) were observed with lisinopril alone: headache (by 3.8%), dizziness (by 3.5%), and cough (by 2.5%). Heart Failure In patients with systolic heart failure treated with lisinopril for up to four years, 11% discontinued therapy with adverse reactions. In controlled studies in patients with heart failure, therapy was discontinued in 8.1% of patients treated with lisinopril for 12 weeks, compared to 7.7% of patients treated with placebo for 12 weeks. The following adverse reactions (events 2% greater…

Who shouldn’t take Qbrelis

QBRELIS is contraindicated in patients with: a history of angioedema or hypersensitivity related to previous treatment with an angiotensin converting enzyme inhibitor hereditary or idiopathic angioedema Do not co-administer aliskiren with QBRELIS in patients with diabetes [see Drug Interactions ( 7.4 )] . QBRELIS is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer QBRELIS within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor [see Warnings and Precautions ( 5.2 )] . Angioedema or a history of hereditary or idiopathic angioedema ( 4 ). Hypersensitivity ( 4 ). Co-administration of aliskiren with QBRELIS in patients with diabetes ( 4 , 7.4 ). In combination with a neprilysin inhibitor ( 4 ).

Qbrelis drug interactions

Diuretics: Excessive drop in blood pressure ( 7.1 ). NSAIDS: Increased risk of renal impairment and loss of antihypertensive efficacy ( 7.3 ). Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension and hyperkalemia ( 7.4 ). Lithium: Symptoms of lithium toxicity ( 7.5 ). Gold: Nitritoid reactions have been reported ( 7.6 ). 7.1 Diuretics Initiation of QBRELIS in patients on diuretics may result in excessive reduction of blood pressure. The possibility of hypotensive effects with QBRELIS can be minimized by either decreasing or discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with QBRELIS. If this is not possible, reduce the starting dose of QBRELIS [see Dosage and Administration ( 2.2 ) and Warnings and Precautions ( 5.4 )] . QBRELIS attenuates potassium loss caused by thiazide-type diuretics. Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) can increase the risk of hyperkalemia. Therefore, if concomitant use of such agents is indicated, monitor the patient’s serum potassium frequently. 7.2 Antidiabetics Concomitant administration of QBRELIS and antidiabetic medicines (insulins, oral hypoglycemic agents) may cause an increased blood-glucose-lowering effect with risk of hypoglycemia. 7.3 Non-Steroidal Anti-Inflammatory Agents Including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including lisinopril, may result in deterioration of renal function, including possible acute renal failure. These effects are usually reversible. Monitor renal function periodically in patients receiving lisinopril and NSAID therapy. The antihypertensive effect of ACE inhibitors, including lisinopril, may be attenuated by NSAIDs. 7.4 Dual Blockade of the Renin-Angiotensin System (RAS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. The VA NEPHRON trial enrolled 1448 patients with type 2 diabetes, elevated urinary-albumin-to-creatinine ratio, and decreased estimated glomerular filtration rate (GFR 30 to 89.9 mL/min), randomized them to lisinopril or placebo on a background of losartan therapy and followed them for a median of 2.2 years. Patients receiving the combination of losartan and lisinopril did not obtain any additional benefit compared to monotherapy for the combined endpoint of decline in GFR, end stage renal disease, or death, but experienced an increased incidence of hyperkalemia and acute kidney injury compared with the monotherapy group. In general, avoid combined use of RAS inhibitors. Closely monitor blood pressure, renal function and electrolytes in patients on QBRELIS and other agents that affect the RAS. Do not co-administer aliskiren with QBRELIS in patients with diabetes. Avoid use of aliskiren with QBRELIS in patients with renal impairment (GFR < 60 mL/min). 7.5 Lithium Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs, which cause elimination of sodium, including ACE inhibitors. Lithium toxicity was usually reversible upon discontinuation of lithium and the ACE inhibitor. Monitor serum lithium levels during concurrent use. 7.6 Gold Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including lisinopril. 7.7 mTOR Inhibitors Patients taking concomitant mTOR inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema [see Warnings and Precautions ( 5.2 )] . 7.8 Neprilysin Inhibitor Patients taking concomitant neprilysin inhibitors may be at increased risk for angioedema [see Warnings and Precautions ( 5.2 )].

Lisinopril and food

Every lisinopril product we track (3)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Lisinopril products
#DrugRatingPharmacy pays
170/100$1View →
270/100$1View →
370/100$1View →

What lisinopril pills look like

Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.

Lisinopril pill imprints
ImprintStrengthColourShape
H;14940 mgyellowcapsule
LUPIN;1010 mgpinkround
55 mgpinkround
LUPIN;1010 mgpinkround
LUPIN;2020 mgpinkround
LUPIN;4040 mgyellowround
LUPIN;4040 mgyellowround
LUPIN;1010 mgpinkround
LUPIN;2020 mgpinkround
55 mgpinkround
H;14720 mgpinkcapsule
LUPIN;2;52.5 mgwhiteround

Combination products containing lisinopril

A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.

Lisinopril recalls

From the FDA Enforcement database. A recall covers specific lots — not the drug as a whole.

How long lisinopril keeps

No lisinopril label we read sets a separate limit for after opening, but they do specify how it must be stored — and the stability behind any date assumes those conditions.

Does lisinopril expire? The in-use limits and storage rules from its labels

Lisinopril and breastfeeding

From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.

Because of the low levels of lisinopril in breastmilk, amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants.

Full LactMed record for lisinopril: levels in milk, effects in breastfed infants, and the drugs it would consider instead

National Institute of Child Health and Human Development, record revised July 15, 2026. LactMed states its information is not a substitute for professional judgement.

What people report to the FDA about lisinopril

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 323,135 reports naming lisinopril, and the FDA flagged 61% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • fatigue21,075 reports
  • nausea19,678 reports
  • diarrhoea18,369 reports
  • dyspnoea14,648 reports
  • dizziness14,412 reports
  • headache13,726 reports
  • vomiting11,530 reports
  • asthenia11,461 reports

Read these as a signal, not a rate. A report does not mean lisinopril caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.

Source: openFDA drug/event (FAERS), retrieved August 25, 2026.

How long lisinopril stays in your system

The elimination half-life of lisinopril is about 12 hours (the effective half-life, in adults with normal kidney function). Lisinopril is not metabolized and is cleared unchanged by the kidneys, so its half-life is longer in people with reduced kidney function and in older adults; how much is absorbed also varies widely between individuals. The 12-hour figure is the label's "effective half-life of accumulation" (the clinically meaningful value), not a single-dose terminal half-life.

LISINOPRIL tablet — DailyMed (FDA label), Clinical Pharmacology / Pharmacokinetics

Half-life is how long the body takes to clear half a dose. It is not the same as how long a drug test can detect it, and it varies with age, kidney and liver function.

Is lisinopril safe during pregnancy?

The label states a known risk

The label carries a boxed warning and a §8.1 Pregnancy risk summary stating lisinopril can cause fetal harm. As a drug acting on the renin-angiotensin system, use in the second and third trimesters reduces fetal renal function and increases fetal and neonatal illness and death; it can cause oligohydramnios leading to reduced fetal kidney function, lung underdevelopment, skull and skeletal deformities, low blood pressure, and death. The label directs that when pregnancy is detected, lisinopril be discontinued as soon as possible. If there is no appropriate alternative, the mother should be told of the potential fetal risk and monitored with serial ultrasounds; exposed infants should be watched for low blood pressure, low urine output, and high potassium. Anyone pregnant or planning pregnancy should consult their prescriber — do not start or stop this medication on your own.

This is what lisinopril’s FDA label says — not a recommendation to take or stop it. In pregnancy, that decision is your prescriber’s; do not start or stop a medicine on your own.

Lisinopril — DailyMed FDA label (§8.1 Pregnancy, boxed warning)

Related guides

Related calculators

Frequently asked questions

What is Qbrelis?

Qbrelis (Lisinopril) is an angiotensin converting enzyme inhibitor used to treat Diabetic Nephropathies, Heart Failure, Hypertension, Myocardial Infarction.

What kind of drug is lisinopril?

The FDA classifies lisinopril as an angiotensin converting enzyme inhibitor. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.

Is lisinopril safe during pregnancy?

The label carries a boxed warning and a §8.1 Pregnancy risk summary stating lisinopril can cause fetal harm. As a drug acting on the renin-angiotensin system, use in the second and third trimesters reduces fetal renal function and increases fetal and neonatal illness and death; it can cause oligohydramnios leading to reduced fetal kidney function, lung underdevelopment, skull and skeletal deformities, low blood pressure, and death. The label directs that when pregnancy is detected, lisinopril be discontinued as soon as possible. If there is no appropriate alternative, the mother should be told of the potential fetal risk and monitored with serial ultrasounds; exposed infants should be watched for low blood pressure, low urine output, and high potassium. Anyone pregnant or planning pregnancy should consult their prescriber — do not start or stop this medication on your own. This is what lisinopril's FDA label says; whether to use it in pregnancy is your prescriber's decision.

How long does lisinopril stay in your system?

The elimination half-life of lisinopril is about 12 hours (the effective half-life, in adults with normal kidney function) — that is how long the body takes to clear half of a dose. Lisinopril is not metabolized and is cleared unchanged by the kidneys, so its half-life is longer in people with reduced kidney function and in older adults; how much is absorbed also varies widely between individuals. The 12-hour figure is the label's "effective half-life of accumulation" (the clinically meaningful value), not a single-dose terminal half-life. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

Can you take lisinopril with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run lisinopril against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What brand names is lisinopril sold under?

We track 3 lisinopril-containing products in the U.S.: Lisinopril, Prinivil and Qbrelis. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

What forms does lisinopril come in?

Across the brands we track, lisinopril is currently marketed as tablet and solution, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic lisinopril?

Yes. Our catalog lists 1 generic lisinopril product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

Has lisinopril been recalled?

The FDA's Enforcement database lists 2 recall records whose product description mentions lisinopril. The most recent: Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg (Jun 20, 2025). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.

How long does it take for lisinopril to work?

Lisinopril starts lowering blood pressure within a few hours of the first dose, but the full effect builds over about 2 to 4 weeks of daily use. Because high blood pressure usually has no symptoms, you will not 'feel' it working — the way to know is by measuring your blood pressure over time.

What should I avoid while taking lisinopril?

Food: salt substitutes containing potassium, and large amounts of potassium-rich foods or supplements — see the food section above for what each one does and whether it means avoiding it or just being consistent. This is what the FDA label and our cited sources say — it is not a complete list. Your pharmacist can check your own combination.

What are the common side effects of lisinopril?

The side effects most people notice are usually mild. MedlinePlus lists cough, dizziness, headache, excessive tiredness, nausea, diarrhea, weakness, sneezing, runny nose, decreased sexual ability, and rash. Dizziness and lightheadedness are most likely when you first start or after a dose increase, because that is when your blood pressure drops the most — standing up slowly helps. Many of these ease as your body adjusts over the first week or two. The one exception is the dry cough, which tends to appear later and does not fade (see below). This is not a complete list; report anything persistent or worsening to your prescriber.

What are the serious side effects of lisinopril — when should I call a doctor or go to the ER?

Get emergency help right away, per MedlinePlus, for: "swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs, hoarseness, difficulty breathing or swallowing." This is angioedema — the most dangerous lisinopril reaction, because throat or tongue swelling can block the airway. Do not wait to see if it passes. Also call your doctor immediately for fever, sore throat, chills or other signs of infection; yellowing of the skin or eyes; lightheadedness or fainting; or chest pain. Angioedema can start at any point in treatment — StatPearls notes it "can occur anytime during therapy but most commonly occurs within the first 3 months" — so a normal first few weeks does not rule it out later.

When do lisinopril side effects start and how long do they last?

It depends on the effect. Dizziness and lightheadedness tend to show up early — with the first doses or after an increase — and usually settle within a week or two as your body adapts. The signature ACE-inhibitor dry cough is different: StatPearls describes "a dry, nonproductive, hacking cough that usually begins within months of initiating therapy and resolves within 1 to 4 weeks after discontinuing." So a new nagging cough weeks or months in can absolutely be the lisinopril, and it does not improve while you keep taking the drug. Angioedema most often appears in the first 3 months but can occur anytime. These are typical patterns, not guarantees — timing varies from person to person.

What are the long-term risks of taking lisinopril, and what does my doctor monitor?

Lisinopril is taken for years, so two lab values are watched: potassium and kidney function. Because ACE inhibitors reduce potassium excretion, StatPearls notes the drug "may result in a slight increase in serum potassium" — higher if you also take potassium-sparing diuretics or potassium-containing salt substitutes, which MedlinePlus says to discuss with your doctor first. Kidney-wise, a small rise in creatinine early on is often "benign" per StatPearls; doctors monitor potassium, blood pressure, and BUN/creatinine after starting and reserve stopping the drug for a "progressive or significant elevation." Regular blood tests catch these before they cause harm — one reason lisinopril is generally considered safe for long-term use under monitoring.

Does the lisinopril cough go away, and can I switch off it?

The dry cough does not fade while you stay on lisinopril — it is triggered by the drug's mechanism, not an allergy or infection, and StatPearls says it "resolves within 1 to 4 weeks after discontinuing." It is a genuine, well-documented reason people are switched to a different blood-pressure drug (commonly an ARB such as losartan, which works similarly without the cough). But do not stop lisinopril on your own — that can send your blood pressure back up. Tell your prescriber; the switch is a routine, prescriber-managed decision, not something to attempt yourself.

Is lisinopril safe during pregnancy?

No. MedlinePlus is explicit: "Do not take lisinopril if you are pregnant. If you become pregnant while taking lisinopril, call your doctor immediately. Lisinopril may harm the fetus." ACE inhibitors can cause serious injury or death to a developing baby, especially in the second and third trimesters. If you are pregnant, planning pregnancy, or think you might be, contact your prescriber right away so they can move you to a blood-pressure medication that is safe in pregnancy — but do not stop treating high blood pressure on your own, as uncontrolled hypertension is also dangerous.

Cite this page
APA
pharmaranks. (2026, July 24). Lisinopril: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/lisinopril
MLA
“Lisinopril: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/lisinopril.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for lisinopril on DailyMed (NIH) ↗ — including its boxed warning in full.